🇺🇸 FDA
Patent

US 8410267

Regioselective reduction of fused pyrrolocarbazoles-5,7-diones

granted A61PA61P35/00

Quick answer

US patent 8410267 (Regioselective reduction of fused pyrrolocarbazoles-5,7-diones) held by Teva Sante expires Mon Mar 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Teva Sante
Grant date
Tue Apr 02 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61P, A61P35/00